Skip to content

Dalhila Solorzano Rubio, MD

NPI 1285197590ActiveIndividual· Pediatrics, Pediatric Endocrinology· Salt Lake City, UT

Pediatrics, Pediatric Endocrinology (MD) in Salt Lake City, Utah, licensed in UT and NM, with an NPI issued in April 2019. Enrolled in Medicare as order and referring only - pediatric medicine. Novo Nordisk Inc reported $73.72 in payments in 2025, mostly food and beverage.

Overview

NPI1285197590
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedApr 12, 2019
Last updated in NPPESJul 17, 2026
Certified by providerJul 17, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Endocrinology Primary2080P0205X13274783-1205UT
Pediatrics208000000XMD2022-1004NM

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Pediatric Medicine (UT)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$73.72 · 1 payment from 1 company
  • 2024$103.92 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$73.721

What the 2025 payments were for

  • Food and Beverage$73.72 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in Salt Lake City

All 15 Pediatrics, Pediatric Endocrinology providers in Salt Lake City · All Pediatrics, Pediatric Endocrinology providers in Utah